Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.72 |
| ▸ | MEN1 | O00255 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.72 |
| ▸ | PGR | P06401 | 3/20 | 0.70 |
| ▸ | AR | P10275 | 3/20 | 0.70 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.63 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.63 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.63 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | CYP19A1 | P11511 | 8/20 | 0.58 |
| ▸ | FNTA | P49354 | 1/20 | 0.58 |
| ▸ | FNTB | P49356 | 1/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1650395 | 1.00 | LMNA (0.72) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL10868391 | 1.00 | LMNA (0.72) | LMNAMEN1KMT2ATDP1PGR | |
| Acetic Acid SCHEMBL4521 | 0.98 | LMNA (0.70) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL8859777 | 0.92 | LMNA (0.67) | LMNAMEN1KMT2ATDP1PGR | |
| Megestrol Acetate SCHEMBL5599601 | 0.90 | AR (0.81) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL11513690 | 0.89 | LMNA (0.58) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL11513687 | 0.89 | LMNA (0.58) | LMNAMEN1KMT2ATDP1PGR | |
| SCHEMBL11512435 | 0.89 | FNTA (0.73) | LMNAMEN1KMT2ATDP1PGR | |
| Melengestrol Acetate SCHEMBL10867312 | 0.84 | LMNA (1.00) | LMNAMEN1KMT2ATDP1PGR | |
| Melengestrol Acetate SCHEMBL16389279 | 0.84 | LMNA (1.00) | LMNAMEN1KMT2ATDP1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2588 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240090533-A1 | METHODS AND FORMULATIONS FOR REDUCING BOVINE EMISSIONS | ELANCO US INC. | 2024-03-21 | — | — | US | claimed |
| US-11864567-B2 | Methods and formulations for reducing bovine emissions | ELANCO US INC. (US) | 2024-01-09 | — | — | US | claimed |
| EP-2116249-B2 | Pharmaceutical compound containing gestagens and/or oestrogens and 5-methyl-(6S)-tetrahydrofolates | BAYER IP GMBH (DE) | 2023-04-05 | — | — | EP | claimed |
| EP-3441089-B1 | TREATMENT METHODS USING ADENOVIRUS | VASCULAR BIOGENICS LTD (IL) | 2022-12-14 | — | — | EP | claimed |
| US-20220240545-A1 | METHODS AND FORMULATIONS FOR REDUCING BOVINE EMISSIONS | ELANCO US INC. | 2022-08-04 | — | — | US | claimed |
| US-11344047-B2 | Methods and formulations for reducing bovine emissions | ELANCO US INC. (US) | 2022-05-31 | — | — | US | claimed |
| CN-114365796-A | Methods and formulations for reducing bovinae animal emissions | 伊兰科美国公司 | 2022-04-19 | — | — | CN | claimed |
| US-20220073444-A1 | Compounds, Compositions, and Methods for use in Treating Autophagy-Associated Disorders | BIOPHAGY INC (US) | 2022-03-10 | — | — | US | claimed |
| CN-108366583-B | Methods and formulations for reducing bovinae animal emissions | 伊兰科美国公司 | 2022-03-01 | — | — | CN | claimed |
| US-11208371-B2 | Compounds, compositions, and methods for use in treating autophagy-associated disorders | BIOPHAGY INC (US) | 2021-12-28 | — | — | US | claimed |
| EP-0591432-A1 | SOLUBILITY PARAMETER BASED DRUG DELIVERY SYSTEM AND METHOD FOR ALTERING DRUG SATURATION CONCENTRATION | NOVEN PHARMACEUTICALS, INC. (US) | 1994-04-13 | — | — | EP | claimed |
| EP-0573576-A1 | COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF PHARMACEUTICALLY ACTIVE AGENTS. | NOVEN PHARMA (US) | 1993-12-15 | — | — | EP | claimed |
| US-5227167-A | LONG-TERM DELIVERY DEVICE INCLUDING HYDROPHOBIC LOADING DOSE | ALZA CORPORATION (US) | 1993-07-13 | — | — | US | claimed |
| WO-1993000058-A1 | SOLUBILITY PARAMETER BASED DRUG DELIVERY SYSTEM AND METHOD FOR ALTERING DRUG SATURATION CONCENTRATION | NOVEN PHARMACEUTICALS, INC. (US) | 1993-01-07 | — | — | WO | claimed |
| WO-1992015289-A1 | COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF PHARMACEUTICALLY ACTIVE AGENTS | NOVEN PHARMACEUTICALS, INC. (US) | 1992-09-17 | — | — | WO | claimed |
| EP-0496520-A1 | Novel bone acting agents | MERCK & CO. INC. (US) | 1992-07-29 | — | — | EP | claimed |
| US-4649042-A | SUSTAINED RELEASE, DRUGS, GLYCOLIC ACID-LACTIC ACID COPOLYMER CORE, TUBES, ELASTICITY, SEALS | ELI LILLY AND COMPANY (US) | 1987-03-10 | — | — | US | claimed |
| US-4567001-A | 16-Methylene-17α-hydroxy-progesterones | THE UPJOHN COMPANY (US) | 1986-01-28 | — | — | US | claimed |
| EP-0164241-A2 | Improvements in or relating to a rumen delivery device | ELI LILLY AND COMPANY (US) | 1985-12-11 | — | — | EP | claimed |
| US-4346037-A | Base catalyzed acylation with enol esters | THE UPJOHN COMPANY (US) | 1982-08-24 | — | — | US | claimed |